These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK. Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865 [Abstract] [Full Text] [Related]
23. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans. Sampathkumar V, Velusamy SK, Godboley D, Fine DH. Sci Rep; 2017 May 15; 7(1):1887. PubMed ID: 28507341 [Abstract] [Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics. Krueger E, Brown AC. Mol Oral Microbiol; 2020 Jun 15; 35(3):85-105. PubMed ID: 32061022 [Abstract] [Full Text] [Related]
25. The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization. Boesze-Battaglia K, Walker LP, Zekavat A, Dlakić M, Scuron MD, Nygren P, Shenker BJ. Infect Immun; 2015 Oct 15; 83(10):4042-55. PubMed ID: 26216427 [Abstract] [Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains. Fong KP, Tang HY, Brown AC, Kieba IR, Speicher DW, Boesze-Battaglia K, Lally ET. Mol Oral Microbiol; 2011 Aug 15; 26(4):262-76. PubMed ID: 21729247 [Abstract] [Full Text] [Related]
27. Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1. Boesze-Battaglia K, Walker LP, Dhingra A, Kandror K, Tang HY, Shenker BJ. Front Cell Infect Microbiol; 2017 Aug 15; 7():469. PubMed ID: 29184850 [Abstract] [Full Text] [Related]
28. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans. Childress C, Feuerbacher LA, Phillips L, Burgum A, Kolodrubetz D. J Bacteriol; 2013 May 15; 195(10):2284-97. PubMed ID: 23475968 [Abstract] [Full Text] [Related]
29. Disorder in cholesterol-binding functionality of CRAC peptides: a molecular dynamics study. Miller CM, Brown AC, Mittal J. J Phys Chem B; 2014 Nov 20; 118(46):13169-74. PubMed ID: 25347282 [Abstract] [Full Text] [Related]
30. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments. Velusamy SK, Sampathkumar V, Godboley D, Fine DH. PLoS One; 2016 Nov 20; 11(3):e0151361. PubMed ID: 26977924 [Abstract] [Full Text] [Related]
31. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli. Balashova N, Giannakakis A, Brown AC, Koufos E, Benz R, Arakawa T, Tang HY, Lally ET. Gene; 2018 Sep 25; 672():106-114. PubMed ID: 29879499 [Abstract] [Full Text] [Related]
32. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. DiFranco KM, Johnson-Farley N, Bertino JR, Elson D, Vega BA, Belinka BA, Kachlany SC. Leuk Res; 2015 Jun 25; 39(6):649-56. PubMed ID: 25850729 [Abstract] [Full Text] [Related]
33. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells. Dietmann A, Millonig A, Combes V, Couraud PO, Kachlany SC, Grau GE. Microb Pathog; 2013 Jun 25; 61-62():43-50. PubMed ID: 23665198 [Abstract] [Full Text] [Related]
34. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans. Crosby JA, Kachlany SC. Gene; 2007 Feb 15; 388(1-2):83-92. PubMed ID: 17116373 [Abstract] [Full Text] [Related]
35. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Diaz R, Ghofaily LA, Patel J, Balashova NV, Freitas AC, Labib I, Kachlany SC. Microb Pathog; 2006 Feb 15; 40(2):48-55. PubMed ID: 16414241 [Abstract] [Full Text] [Related]
36. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans. Balashova NV, Park DH, Patel JK, Figurski DH, Kachlany SC. Infect Immun; 2007 Sep 15; 75(9):4490-7. PubMed ID: 17635874 [Abstract] [Full Text] [Related]
37. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Johansson A. Toxins (Basel); 2011 Mar 15; 3(3):242-59. PubMed ID: 22069708 [Abstract] [Full Text] [Related]
38. The Extracellular Domain of the β2 Integrin β Subunit (CD18) Is Sufficient for Escherichia coli Hemolysin and Aggregatibacter actinomycetemcomitans Leukotoxin Cytotoxic Activity. Ristow LC, Tran V, Schwartz KJ, Pankratz L, Mehle A, Sauer JD, Welch RA. mBio; 2019 Jul 09; 10(4):. PubMed ID: 31289186 [Abstract] [Full Text] [Related]
39. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis. Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC. Toxins (Basel); 2010 Dec 09; 2(12):2824-36. PubMed ID: 22069577 [Abstract] [Full Text] [Related]
40. Cranberry Proanthocyanidins Neutralize the Effects of Aggregatibacter actinomycetemcomitans Leukotoxin. Ben Lagha A, Howell A, Grenier D. Toxins (Basel); 2019 Nov 14; 11(11):. PubMed ID: 31739483 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]